Wells Fargo & Company Alector, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Alector, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 21,879 shares of ALEC stock, worth $94,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,879
Previous 16,693
31.07%
Holding current value
$94,954
Previous $133,000
1.5%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ALEC
# of Institutions
161Shares Held
59.8MCall Options Held
67.8KPut Options Held
200-
Black Rock Inc. New York, NY8.48MShares$36.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$21.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.06MShares$17.6 Million0.7% of portfolio
-
State Street Corp Boston, MA3.92MShares$17 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.77MShares$16.4 Million0.75% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $358M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...